Related Experiment Video
Updated: May 5, 2026
Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
An optimized Fmoc synthesis of human defensin 5
Ermelinda Vernieri1, Javier Valle, David Andreu
1Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona Biomedical Research Park, Dr. Aiguader 88, 08003, Barcelona, Spain.
Abstract:
Human α-defensin 5 (DEF5), expressed by the Paneth cells of human small intestine, plays an important role in host defense against microbial infections. DEF5, a 32-residue peptide adopting a three-stranded β-sheet fold stabilized by three internal disulfide bonds, is not efficiently produced by recombinant expression techniques and is, therefore, an interesting goal for chemical synthesis. While DEF5 production by Boc-based solid-phase synthesis has been described, to date no synthetic account by the more convenient Fmoc method has been published. Herein, we report an optimized solid-phase synthesis of DEF5 using the Fmoc strategy. Starting from a rather problematic initial synthesis using standard Wang resin and coupling protocols, the sequence elongation process has been monitored by mini-cleavage and MS analysis at strategic points, to identify problematic spots and act accordingly. For expediency, some of the optimization rounds have been run on defensin 5 amide. Main modifications have included the ChemMatrix(®) resin, known to decrease chain aggregation, and the use of pseudoproline dipeptide units at selected positions. Combination of some of these improvements results in a significantly purer product, to the extent that it can undergo in situ anaerobic oxidative folding to the native form without the need of an intermediate purification step. A typical synthesis run yielded about 15 mg of >95 % pure material. This approach should facilitate production of DEF5 and of selected analogs for structure-activity studies and other applications.
Insights
Chemists developed an improved Fmoc solid-phase synthesis for human alpha-defensin 5 (DEF5), a key antimicrobial peptide. This method efficiently produces high-purity DEF5 for research and therapeutic applications.
Area of Science:
- Biochemistry
- Peptide Synthesis
- Immunology
Background:
- Human alpha-defensin 5 (DEF5) is a crucial antimicrobial peptide produced by intestinal Paneth cells.
- DEF5's complex structure and difficulty in recombinant production make chemical synthesis a vital alternative.
- Previous chemical synthesis relied on the less convenient Boc strategy, with no published Fmoc-based methods.
Purpose of the Study:
- To develop and optimize an Fmoc-based solid-phase synthesis for human alpha-defensin 5 (DEF5).
- To overcome challenges in synthesizing DEF5, including aggregation and low yield.
- To establish a reliable method for producing pure DEF5 for further studies.
Main Methods:
- Utilized Fmoc solid-phase synthesis strategy.
- Employed ChemMatrix® resin to minimize peptide chain aggregation.
- Incorporated pseudoproline dipeptide units at specific sequence positions.
- Monitored synthesis progress using mini-cleavage and mass spectrometry (MS).
Main Results:
- Optimized Fmoc synthesis yielded significantly purer DEF5 (>95%).
- Achieved efficient in situ anaerobic oxidative folding to the native DEF5 form without intermediate purification.
- A typical synthesis run produced approximately 15 mg of purified DEF5.
- Identified and addressed problematic sequence elongation steps through iterative optimization.
Conclusions:
- The optimized Fmog-based solid-phase synthesis provides an efficient route to human alpha-defensin 5.
- This improved method facilitates the production of DEF5 and its analogs for structure-activity relationship studies.
- The developed approach enhances the accessibility of DEF5 for research and potential therapeutic applications.
